Asia-Pacific
While IP Australia’s updated manual could be favourable to computer-implemented inventions, stakeholders would like to see whether a consistent and reliable standard is followed during actual examination
Patent partner Robert Hollingshead explains why the firm remains committed to Japan despite several US firms exiting the Japanese and greater Asia market
The High Court of Australia has allowed a fashion designer to retain her registered ‘Katie Perry’ trademark for clothing
Sim & San secured the win for Dr. Reddy’s, which will allow the pharma company to manufacture and export semaglutide, the active ingredient in Ozempic
Sponsored
Sponsored
-
Sponsored by Liu, Shen & AssociatesGuanyang Yao of Liu, Shen & Associates highlights a revised approach to standard-essential patent protection and a recent Huawei–Netgear infringement case that exemplifies the balancing of interests between rights holders and implementers
-
Sponsored by De Penning & De PenningAnand Barnabas and Anandan S of De Penning & De Penning explain how businesses with a strong technology and R&D focus can use freedom-to-operate searches to mitigate intellectual property infringement risks and target growth through innovation
-
Sponsored by Wanhuida Intellectual PropertyJicheng Yang and Jianhui Li of Wanhuida Intellectual Property draw on insights from CNIPA practice in discussing how different drafting approaches to crystal form patent claims impact protection scope and patent validity
-
Sponsored by RNA, Technology and IP AttorneysRanjan Narula, Swati Dalal, and Vanshika Oberoi of RNA, Technology and IP Attorneys explore the legal framework, challenges, and enforcement strategies for protecting well-known trademarks in India
-
Sponsored by Tilleke & GibbinsAdirek Siriwattasit of Tilleke & Gibbins says Thailand’s new fast-track patent programme for green technologies offers accelerated examinations at no extra cost to applicants, promotes sustainable innovation, and modernises the country’s intellectual property landscape
-
Sponsored by Hanol IP & LawMin Son of Hanol IP & Law says pharmaceutical R&D in South Korea should be enhanced on the introduction of a clearer legal framework that offers improved market protection for new and modified drugs